University of Colorado Cancer Center

 

University of Colorado Cancer Center
E

Overview of HR+/HER2+ BC: Prevalence in the US, Subtypes, and Designing Targeted Drug Combinations

By University of Colorado Cancer Center FEATURING Elena Shagisultanova
By University of Colorado Cancer Center FEATURING Elena Shagisultanova
184 views
June 23, 2021
0 Comments
Login to view comments. Click here to Login
Oncology Grand Rounds
46:54
University of Colorado Cancer Center

Targeting Transcriptional Addiction in High-Risk Pediatric Cancers W…

Feat. A. Durbin
48:02
University of Colorado Cancer Center

Computational Modeling of the Tumor Ecosystem

Feat. S. Finley
47:26
University of Colorado Cancer Center

Discovery of Targets for Bipotent Anticancer Drug

Feat. A. Sahu
46:48
University of Colorado Cancer Center

Theranostics and the Changing Face of Prostate Cancer

Feat. M. Morris
36:02
University of Colorado Cancer Center

Multicancer Early Detection Assays: Are They Ready for Prime Time?

Feat. M. Wood
53:57
University of Colorado Cancer Center

What Will It Take to Cure Cancer? Historical Context and Future Dire…

Feat. C. Lieu
45:51
University of Colorado Cancer Center

Adventures in Keratinocyte Carcinoma Chemoprevention

Feat. M. Weinstock
41:41
University of Colorado Cancer Center

Increasing Epitope Spreading to Improve CAR-T Therapy for Solid Tumo…

Feat. M. Leibowitz
55:46
University of Colorado Cancer Center

UColorado Updates on Hepatocellular Carcinoma and Biliary Tract Canc…

Feat. L. Davis
50:41
University of Colorado Cancer Center

NKT Cell Development and Activation: Implications in Cancer Immunoth…

Feat. T. Webb
39:22
University of Colorado Cancer Center

Prevention of Obesity-Associated Colorectal Cancer: Mechanistic Appr…

Feat. C. V. Rao
30:24
University of Colorado Cancer Center

MRD in MM: How We Measure Disease Generally and What It Means for th…

Feat. B. Harry
40:19
University of Colorado Cancer Center

Practical Principles of Biomarker Testing in Advanced Non-Small Cell…

Feat. T. Patil
40:38
University of Colorado Cancer Center

CAR T-Cell and BiTE Therapy for mCRPC: Trials and Tribulations

Feat. T. Barauskas Dorff
37:39
University of Colorado Cancer Center

How Molecular Analysis for Endometrial Cancer Effects Treatment

Feat. B. Corr
60:49
University of Colorado Cancer Center

Advanced Stage Melanoma in 2021: Disease Overview & Management o…

Feat. T. Medina
41:18
University of Colorado Cancer Center

2021 Advances in Bladder Cancer and Immunotherapy

Feat. T. Flaig
43:13
University of Colorado Cancer Center

Translational Immunotherapy in Sarcomas: Distinct Immune Subsets and…

Feat. B. Wilky
16:30
University of Colorado Cancer Center

2021 Updates on Gynecologic Oncology: Impact on Patients, Overview o…

Feat. B. Bitler, S. Guntupalli, C. Walsh
15:20
University of Colorado Cancer Center

CAR T-Cells & Cancer Immunotherapy: Overview of Different Approa…

Feat. C. Smith, E. Davila, M. Kamdar, B. Wilky
56:18
University of Colorado Cancer Center

Best Practices in Flow and Mass Cytometry-Based Research: From Exper…

Feat. E. Clambey
10:02
University of Colorado Cancer Center

Updates in Neuro-Oncology & New Technologies: Impact on Patients…

Feat. D. Damek, K. Lillehei, W. Messersmith
06:41
University of Colorado Cancer Center

Updates in Neuro-Oncology: The Use of 3D Imaging

Feat. D. Damek, K. Lillehei, W. Messersmith
07:51
University of Colorado Cancer Center

Updates in dMMR/MSI CRC: Overview of Recent Immunotherapy Advances

Feat. W. Messersmith
16:17
University of Colorado Cancer Center

Timely Diagnosis of Pediatric Brain Tumors: General Approach to Visi…

Feat. A. Green
13:38
University of Colorado Cancer Center

Colorado University Updates on Lung Cancer Research: The Future for …

Feat. R. Camidge, J. Degregori
17:45
University of Colorado Cancer Center

Early-Onset Colorectal Cancer Case: Expert Discussion

Feat. C. Bradley, J. Vogel, C. Lieu
14:36
University of Colorado Cancer Center

Expert Discussion on Pancreatic Cancer Research: Impact on Patients …

Feat. M. Del Chiaro, S. Karam, C. Meguid
10:18
University of Colorado Cancer Center

Colorado University Highlights on Prostate Cancer Research: Unmet Ne…

Feat. T. Flaig, E. Kessler, S. Kim, P. Maroni
09:31
University of Colorado Cancer Center

Colorado University Updates on Breast Cancer Research: Impact on Pat…

Feat. J. Diamond, V. Borges
14:57
University of Colorado Cancer Center

Colorado University Highlights on BC Research: Inhibiting Tumor Cell…

Feat. H. Ford, J. Richer, T. Lyons
37:29
University of Colorado Cancer Center

Liquid Biopsies for Pediatric Sarcomas: Can We Use Them in Targeting…

Feat. M. Hayashi
18:14
University of Colorado Cancer Center

Overview of HR+/HER2+ BC: Prevalence in the US, Subtypes, and Design…

Feat. E. Shagisultanova
10:59
University of Colorado Cancer Center

Triplet Targeting Combination in HR+/HER2+ BC: Understanding Signali…

Feat. E. Shagisultanova
10:50
University of Colorado Cancer Center

Surveying Efficacy Data of Tucatinib, Palbociclib and Letrozole Comb…

Feat. E. Shagisultanova
36:50
University of Colorado Cancer Center

Targeting Advanced Prostate Cancer With a Focus on RB-Deficient Tumo…

Feat. K. Knudsen
52:08
University of Colorado Cancer Center

Intrapatient Subpopulation Heterogeneity and the Potential Ramificat…

Feat. D. Sherbenou
11:03
University of Colorado Cancer Center

Updates on TNBC: Risk Factors, Hereditary Syndromes, Screening for M…

Feat. J. Diamond
07:12
University of Colorado Cancer Center

TNBC Highlights: 3D Mammography, MRI, Chemoprevention, Basic Biology

Feat. J. Diamond
34:36
University of Colorado Cancer Center

Management of Early Stage and Metastatic TNBC: Principles of Neoadju…

Feat. J. Diamond
10:43
University of Colorado Cancer Center

MET Signaling in NSCLC: Importance of Biomarker Development & Ba…

Feat. T. Patil
08:13
University of Colorado Cancer Center

Diagnostic Challenges of MET Signaling in NSCLC: Polysomy vs. Amplif…

Feat. T. Patil
10:37
University of Colorado Cancer Center

Brain Mets & CNS Coverage of MET Signaling in NSCLC: Alectinib v…

Feat. T. Patil
09:36
University of Colorado Cancer Center

Future Directions in MET Signaling in NSCLC: Developing Novel Biomar…

Feat. T. Patil
38:12
University of Colorado Cancer Center

CTNNB1 Mutation in Endometrial Cancer: Rationale for Wnt Inhibition …

Feat. B. Corr
16:12
University of Colorado Cancer Center

Venetoclax in Acute Myeloid Leukemia: Targeting BCL-2, Drug Developm…

Feat. D. Pollyea
29:56
University of Colorado Cancer Center

Venetoclax Combinations in AML: Addition of Aza/Dec in Previously Un…

Feat. D. Pollyea